AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Genomics

Showing 101 to 110 of 950 articles

Clear Filters

The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution.

Functional & integrative genomics
Artificial intelligence (AI) platforms have emerged as pivotal tools in genetics and molecular medicine, as in many other fields. The growth in patient data, identification of new diseases and phenotypes, discovery of new intracellular pathways, avai...

Toward Realizing the Promise of AI in Precision Health Across the Spectrum of Care.

Annual review of genomics and human genetics
Significant progress has been made in augmenting clinical decision-making using artificial intelligence (AI) in the context of secondary and tertiary care at large academic medical centers. For such innovations to have an impact across the spectrum o...

Utilizing Deep Neural Networks to Fill Gaps in Small Genomes.

International journal of molecular sciences
With the widespread adoption of next-generation sequencing technologies, the speed and convenience of genome sequencing have significantly improved, and many biological genomes have been sequenced. However, during the assembly of small genomes, we st...

Phenotype prediction using biologically interpretable neural networks on multi-cohort multi-omics data.

NPJ systems biology and applications
Integrating multi-omics data into predictive models has the potential to enhance accuracy, which is essential for precision medicine. In this study, we developed interpretable predictive models for multi-omics data by employing neural networks inform...

Current genomic deep learning models display decreased performance in cell type-specific accessible regions.

Genome biology
BACKGROUND: A number of deep learning models have been developed to predict epigenetic features such as chromatin accessibility from DNA sequence. Model evaluations commonly report performance genome-wide; however, cis regulatory elements (CREs), whi...

A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study.

Theranostics
: This study aims to assess whole-mount Gleason grading (GG) in prostate cancer (PCa) accurately using a multiomics machine learning (ML) model and to compare its performance with biopsy-proven GG (bxGG) assessment. : A total of 146 patients with PCa...

Genome analysis through image processing with deep learning models.

Journal of human genetics
Genomic sequences are traditionally represented as strings of characters: A (adenine), C (cytosine), G (guanine), and T (thymine). However, an alternative approach involves depicting sequence-related information through image representations, such as...

SonicParanoid2: fast, accurate, and comprehensive orthology inference with machine learning and language models.

Genome biology
Accurate inference of orthologous genes constitutes a prerequisite for comparative and evolutionary genomics. SonicParanoid is one of the fastest tools for orthology inference; however, its scalability and accuracy have been hampered by time-consumin...

Using machine learning to combine genetic and environmental data for maize grain yield predictions across multi-environment trials.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik
Incorporating feature-engineered environmental data into machine learning-based genomic prediction models is an efficient approach to indirectly model genotype-by-environment interactions. Complementing phenotypic traits and molecular markers with hi...

Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms.

Diabetes & metabolic syndrome
INTRODUCTION: In 2021, the International Diabetes Federation reported that 537 million people worldwide are living with diabetes. While glucagon-like peptide-1 agonists provide significant benefits in diabetes management, approximately 40% of patient...